Human Papillomavirus (HPV) Vaccine Coverage Achievements in Low and Middle-Income Countries 2007–2016
This article, published in Papillomavirus Research, provides an analysis of HPV vaccine dose coverage in 41 low- and middle-income countries (LMICs) between 2007 and 2016. According to the authors, final coverage estimates were all above 50 percent, with the majority between 70 and 90 percent. Most delivery strategies included schools as a vaccination venue; in countries with school enrollment rates below 90 percent, delivery strategies that included outreach centers and facilities to reach out-of-school girls resulted in higher dose coverage estimates compared to school-only programs. These data demonstrate high HPV vaccine uptake and coverage in LMICs.
Author: Gallagher KE, Howard N, Kabakama S, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Gallagher KE, Howard N, Kabakama S, et al. Human Papillomavirus (HPV) Vaccine Coverage Achievements in Low and Middle-Income Countries 2007–2016. Papillomavirus Research. 2017;4:72-78.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)